Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1966 1
1968 1
1972 1
1973 2
1975 1
1976 1
1977 1
1979 3
1980 6
1981 2
1983 1
1984 1
1986 3
1987 2
1989 1
1990 2
1991 7
1992 3
1993 2
1994 3
1995 2
1996 6
1998 7
1999 10
2000 4
2001 7
2002 10
2003 8
2004 13
2005 7
2006 15
2007 7
2008 20
2009 18
2010 15
2011 13
2012 18
2013 16
2014 8
2015 17
2016 21
2017 23
2018 25
2019 34
2020 34
2021 36
2022 45
2023 23
2024 31
2025 42
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

517 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean osatake h[Author] (10 results)?
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, Karaseva N, Caglevic C, Villanueva L, Goekkurt E, Satake H, Enzinger P, Alsina M, Benson A, Chao J, Ko AH, Wainberg ZA, Kher U, Shah S, Kang SP, Tabernero J. Shitara K, et al. Among authors: satake h. JAMA Oncol. 2020 Oct 1;6(10):1571-1580. doi: 10.1001/jamaoncol.2020.3370. JAMA Oncol. 2020. PMID: 32880601 Free PMC article. Clinical Trial.
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
Strickler JH, Satake H, George TJ, Yaeger R, Hollebecque A, Garrido-Laguna I, Schuler M, Burns TF, Coveler AL, Falchook GS, Vincent M, Sunakawa Y, Dahan L, Bajor D, Rha SY, Lemech C, Juric D, Rehn M, Ngarmchamnanrith G, Jafarinasabian P, Tran Q, Hong DS. Strickler JH, et al. Among authors: satake h. N Engl J Med. 2023 Jan 5;388(1):33-43. doi: 10.1056/NEJMoa2208470. Epub 2022 Dec 21. N Engl J Med. 2023. PMID: 36546651 Free PMC article. Clinical Trial.
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors.
Nakamura Y, Ozaki H, Ueno M, Komatsu Y, Yuki S, Esaki T, Taniguchi H, Sunakawa Y, Yamaguchi K, Kato K, Denda T, Nishina T, Takahashi N, Satoh T, Yasui H, Satake H, Oki E, Kato T, Ohta T, Matsuhashi N, Goto M, Okano N, Ohtsubo K, Yamazaki K, Yamashita R, Iida N, Yuasa M, Bando H, Yoshino T. Nakamura Y, et al. Among authors: satake h. Nat Med. 2025 Jan;31(1):165-175. doi: 10.1038/s41591-024-03244-8. Epub 2024 Sep 16. Nat Med. 2025. PMID: 39284955 Free PMC article.
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.
Koyama T, Kiyota N, Boku S, Imamura Y, Shibata N, Satake H, Tanaka K, Hayashi H, Onoe T, Asada Y, Yamazaki T, Nose T, Ohata S, Nagatani Y, Kimbara S, Funakoshi Y, Teshima M, Shinomiya H, Minami H. Koyama T, et al. Among authors: satake h. ESMO Open. 2024 Jun;9(6):103476. doi: 10.1016/j.esmoop.2024.103476. Epub 2024 Jun 3. ESMO Open. 2024. PMID: 38833968 Free PMC article. Clinical Trial.
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.
Sakai D, Kadowaki S, Kawabata R, Hara H, Satake H, Takahashi M, Takeno A, Imai H, Minashi K, Kawakami T, Boku S, Matsuyama J, Sakamoto Y, Sawada K, Kataoka M, Kawakami H, Shimokawa T, Boku N, Satoh T. Sakai D, et al. Among authors: satake h. J Clin Oncol. 2025 Jul;43(19):2196-2207. doi: 10.1200/JCO.24.01119. Epub 2025 May 23. J Clin Oncol. 2025. PMID: 40408613 Free PMC article. Clinical Trial.
Urochordate immunity.
Nonaka M, Satake H. Nonaka M, et al. Among authors: satake h. Adv Exp Med Biol. 2010;708:302-10. doi: 10.1007/978-1-4419-8059-5_15. Adv Exp Med Biol. 2010. PMID: 21528704 Review.
Ovarian Follicle Development in Ascidians.
Satake H, Kawada T, Osugi T, Sakai T, Shiraishi A, Yamamoto T, Matsubara S. Satake H, et al. Zoolog Sci. 2024 Feb;41(1):60-67. doi: 10.2108/zs230054. Zoolog Sci. 2024. PMID: 38587518 Review.
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
Osumi H, Shinozaki E, Nakamura Y, Esaki T, Yasui H, Taniguchi H, Satake H, Sunakawa Y, Komatsu Y, Kagawa Y, Denda T, Shiozawa M, Satoh T, Nishina T, Goto M, Takahashi N, Kato T, Bando H, Yamaguchi K, Yoshino T. Osumi H, et al. Among authors: satake h. Nat Commun. 2024 Jul 13;15(1):5885. doi: 10.1038/s41467-024-50026-4. Nat Commun. 2024. PMID: 39003289 Free PMC article.
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study.
Sawada K, Yamashita R, Sakai SA, Horasawa S, Yoshikawa A, Fujisawa T, Kadowaki S, Kato K, Ueno M, Oki E, Komatsu Y, Chiyoda T, Horita Y, Yasui H, Denda T, Satake H, Esaki T, Satoh T, Takahashi N, Yamazaki K, Matsuhashi N, Nishina T, Takeda H, Ohtsubo K, Ohta T, Tsuji A, Goto M, Kato T, Bando H, Tsuchihara K, Nakamura Y, Yoshino T. Sawada K, et al. Among authors: satake h. Cancer Res Commun. 2025 May 1;5(5):857-870. doi: 10.1158/2767-9764.CRC-24-0543. Cancer Res Commun. 2025. PMID: 40341952 Free PMC article.
517 results